Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05590637 · ClinicalTrials.gov registry record · Phase 4

Comparing Antipsychotic Medications in LBD Over Time

A Phase 4 study of Dementia With Lewy Bodies and Parkinson's Disease Psychosis, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
Phase 4
Development phase
94
Enrollment target
2
Study locations

NCT05590637 is a Phase 4 study of Dementia With Lewy Bodies and Parkinson's Disease Psychosis that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 94 participants, below the 467-participant average among 22 other Dementia With Lewy Bodies trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05590637, a Phase 4 study of Dementia With Lewy Bodies and Parkinson's Disease Psychosis, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
Phase 4
Development phase
94 participants
Enrollment target
2
Study locations

Study Summary

The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (DLB) - collectively referred to as Lewy body disease (LBD).

Conditions Studied

Dementia With Lewy Bodies Parkinson's Disease Psychosis

Interventions

  • DRUG Quetiapine
  • DRUG Pimavanserin

Study Locations (2)

Texas

  • University Health System - San Antonio
  • UT Health Science Center - San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2022-04-22
Est. Completion 2027-02
Phase Phase 4

Sponsor

The University of Texas Health Science Center at San Antonio

378 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05590637

The ClinicalTrials.gov registry entry for NCT05590637 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 467-participant average among 22 other Dementia With Lewy Bodies trials with a reported enrollment target (80% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia With Lewy Bodies appearing as the primary indexed condition, and to 2 interventions - of which Quetiapine is the first listed.

NCT05590637 reports 2 study locations spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05590637 about?

NCT05590637 is a clinical study titled "Comparing Antipsychotic Medications in LBD Over Time". The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis when used in a routine clinical setting to treat hallucinations and/or delusions due to Parkinson's disease (PD) or dementia with Lewy bodies (D...

What is the current status of trial NCT05590637?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 94 participants. The study started on 2022-04-22. Estimated completion is 2027-02.

What conditions does trial NCT05590637 study?

This clinical trial studies the following conditions: Dementia With Lewy Bodies, Parkinson's Disease Psychosis.

What interventions are being tested in trial NCT05590637?

The interventions under investigation include: Quetiapine (DRUG), Pimavanserin (DRUG).

Who is sponsoring clinical trial NCT05590637?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05590637 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Dementia With Lewy Bodies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Dementia With Lewy Bodies

All registered trials for this condition

Parkinson's Disease Psychosis

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.